Oncology Medical News about ovarian cancer

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Epithelial–mesenchymal transition in ovarian cancer
Cancer Letters, 11/05/09

Vergara D et al. – EMT is believed to be governed by signals from the neoplastic microenvironment including a variety of cytokines and growth factors. In ovarian cancer EMT is induced by transforming growth factor–beta (TGF–beta), epidermal growth factor (EGF), hepatocyte growth factor (HGF) and endothelin–1 (ET–1). Alterations in these cellular pathways candidate them as useful target for ovarian cancer treatment.

<< Previous
Reduced frequency of regulatory T cells in peripheral blood stem...

Next >>
Rapid, flow cytometric assay for NK alloreactivity reveals...

Preventing future cancers by testing women with ovarian cancer for brca mutations
Journal of Clinical Oncology, 10/22/09 Relevance Score: 72%

Activity of the multikinase inhibitor dasatinib against ovarian cancer cells
British Journal of Cancer, 11/02/09 Relevance Score: 70%

Unusual Metals Could Forge New Cancer Drug
ScienceDaily, 10/20/09 Relevance Score: 70%

New Drug Aims To Seek And Destroy Many Types Of Cancer
ScienceDaily, 10/07/09 Relevance Score: 70%

New drug aims to seek and destroy many types of cancer
EurekAlert, 10/06/09 Relevance Score: 70%